Obesity and polycystic ovary syndrome in young girls;Adipositas und PCO-syndrom bei jungen madchen

Gynakologe

Volumn 31, Issue 6, 1998, Pages 566-574

  Wolf, A S ^a,b  

^a Gynakol Gemeinschaftspraxis ^*

^b Gynakol Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIANDROGEN; CHLORMADINONE ACETATE PLUS MESTRANOL; DEXAMETHASONE; DIANE; DIENOGEST; INSULIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE;

ADOLESCENT; CHILD; ENDOCRINOLOGY; FEMALE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOGENESIS; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; REVIEW; UNITED STATES;

EID: 0031806474     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001290050298     Document Type: Review

References (61)

1. Adashi EY, Resnick EC, Brodie AMH, Svoboda ME, Van Wyk JJ (1985) Somatomedin-C enhances induction of luteinizing hormone receptors by follicle-stimulating hormone in cultured rat granulosa cells. Endocrinology 116 2369-2375
2. Apter D, Butzow T, Laughlin GA, Yen SSC (1994) Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovary syndrome. J Clin Endocrinol Metabol 79: 119-125
3. Barash IB, Clement CC, Weigle DS et al. (1996) Leptin is a metabolic signal of the reproductive system. Endocrinology 137 3144-3147
4. Boden G, Chen X, Mozzol M, Ryan I (1996) Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81: 3419-3423
5. Bouchard C (1992) Genetic aspects of human obesity. Lippincott, Philadelphia, pp 343-351
6. Bray GA (1991) The inheritance of corpulence. In: Cioffi LA, James WPT, Itallie TB van (eds) The body weight regulatory system. Raven, New York, pp 41-49
7. Carey A, Waterworth D, Patel K et al. (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene. Hum Mol Genetic 3 1873-1876
8. Cara JF, Rosenfield RL (1988) Insulin-like-growth factor I and insulin potentiate luteinizing hormone induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123: 733-739
9. Considine RV, Sinha MK, Heimann ML et al. (1996) Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 334. 292-295
10. Ehrmann DA, Rosenfield RL, Barnes et al. (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327: 157-162
11. Ehrmann DA, Jeppe S, Byrne M et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-inuslin-dependent diabetes mellitus. J Clin Invest 96: 520-527
12. Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16: 322-353
13. El-Roeiy A, Chen X, Roberts VJ et al. (1994) Expression of the genes encoding the insulin-like-growth-factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding-proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78: 1438-1496
14. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosis factor-α suppresses insulin induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058
15. Frayn KN (1993) Insulin resistance and lipid metabolism. Curr Opin Lipidol 4: 197-204
16. Geisthovel J (1992) Polyzystisches Ovar. Ovarielle Hyperandrogenämie im Jugendalter. DIA-GM 18: 1545-1549
17. Geisthovel J (1994) Was ist primär: Insulinresistenz, Hyperandrogenämie, Adipositas, gestorte Pubertät? In. Molz L (Hrsg) Hyperandrogenamie (HA): Schwerpunktfragen aus Diagnostik und Therapie. Zweite Arbeitstagung der Sektion Angewandte Endokrinologie der DGGG. Darmstadt, E.Merck, S 129-132
18. Geisthovel F, Olbrich M, Frorath B, Thiemann M, Weitzell R (1994) Obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in premenopausal women. Hum Reprod 9: 610-616
19. Geisthovel F, Forth B, Brabant G (1996) Acarbose reduces elevated testosterone serum concentrations in hyperinsulinemic premenopausal women: a pilot study. Hum Reprod 11: 2377-2381
20. Gibson R (1990) The principles of nutritional assessment. Oxford University Press, Oxford, pp 187-208
21. Goldzieher MW, Green JA (1962) The polycystic ovary. I Clinical and histologic features. J Clin Endocrinol Metab 22: 325-338
22. Goodyear U, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204
23. Gostmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH (1993) Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329: 1008-1012
24. Hauner H (1995) Abdominelle Adipositas und koronare Herzkrankheit. Herz 20: 47-55
25. Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J (1995) Effects of tumor necrosis factor alpha (TNF-α) on glucose transport and lipid metabolism in cultured human fat cells. Diabetologia 38: 764-771
26. Hauner H (1995) Pathophysiologische Grundlagen der Insulinresistenz. In: Diehm C, Schettler G (Hrsg) Das metabolische Syndrom. Medikon, München, S 15-25
27. Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY (1988) Somatomedin-C/insulin-like-growth factor-1 (Sm-C/IGF-1) as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology 122 1603-1612
28. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259: 87-91
29. Hsueh A, Billig H, Tsafiri A (1994) Ovarian follicle atresia: a hormonally controlled apopoptic process. Endocrine Rev 15: 707-724
30. Kahn CR, Flier JS, Bar RS et al. (1976) The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 294: 743-745
31. Legro RS, Muhleman DR, Comings DE et al. (1995) A dopamine D 3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics. Fertil Steril 63: 779-784
32. Loffler G (1997) Stoffwechsel der Lipide. In: Loffler G, Pertndes PE (Hrsg) Biochemie und Pathobiochemie Berlin. Springer, Berlin Heidelberg New York, S 425-481
33. Löffler G (1997) Endokrine Gewebe II: Die schnelle Stoffwechselregulation. In: Loffler G (Hrsg) Petrides Biochemie und Pathobiochemie Berlin. Springer, Berlin Heidelberg New York, S 787-811
34. Mantzoros CS, Flier JS, Rogol AD (1997) A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 8: 1066-1070
35. Moller DE, Cohen O, Yamaguchi Y et al. (1994) Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43: 247-255
36. Mossberg HO (1989) 40-year follow up of overweight children. Lancet 2 491-493
37. Nestler J (1993) Sex hormone-binding globulin: A marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 76: 273-274
38. Nestler J, Jakubowicz D (1996) Decreases in ovarian cytochrome P450d 17α activity and serum free testosterone after reduction of insulin secretion in women with polycystic ovary syndrome. N Engl J Med 335 617-623
39. Nestler JE, Clore JN, Blackard WG (1985) The central role of obesity in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol 161: 1095-1097
40. Nestler JE, Powers LP, Matt DW (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72: 83-89
41. Poretsky L, Clemons J, Bogovich K (1992) Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism 41: 903-910
42. Poretsky L, Piper B (1994) Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 84: 613-621
43. Poskitt EME, Cole TJ (1977) Do fat babies stay fat? Br Med J 1: 7-9
44. Poskitt EME (1995) The fat child. In: Brook CGD (ed) Clinical pediatric endocrinology. Blackwell, Oxford, pp 210-233
45. Pudel V, Chome J, Menden E et al. (1984) Psychosoziale Bewertung der Ernährung in Familien mit Kindern. Eine Repräsentativerhebung in der Bundesrepublik Deutschland. Emah-rungsbericht 84: 103-144
46. Rosenfield RL, Barnes RH, Ehrmann DA (1994) Studies of nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79: 1686-1692
47. Rosenfield RL (1997) Current concepts of polycystic ovary syndrome. Bailliere's Clin Obstet Gynecol 11: 307
48. Schneider R, Eberhardt W, Heseker H, Moth KJ (1992) Die VERA-Stichprobe im Vergleich mit Volkszählung, Mikrozensus und anderen nationalen Untersuchungen, Band II. In: Kubler W, Anders HJ, Heeschen W, Kohlmeier M (Hrsg) VERA-Schriftenreihe Wissenschaftlicher Fachverlag Dr, Fleck, Niederhleen
49. Schwartz MW, Seeley RJ (1997) Neuroendocrine responses to starvation and weight loss. N Engl J Med 336: 1802-1811
50. Spinder T, Spijkstra J, van den Tweel JG et al. (1989) The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol 69: 151-157
51. Stunkard AJ, Sorensen TA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F (1986) An adoption study of human obesity. N Engl J Med 314: 193-198
52. Svedberg J, Bjorntop P, Smith U, Lönnroth P (1990) Free fatty acid inhibition of insulin binding, degradation, and action in isolated hepatocytes. Diabetes 39. 570-574
53. Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K, Kitao M (1994) Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovary syndrome. Hum Reprod 9: 1231-1236
54. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P (1982) Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med 97 851-855
55. Taylor SI, Kadowaki T, Kadowaki H, Accilli D, Cama A, McKeon C (1990) Mutations in insulin receptor gene in insulin resistant patients. Diabetes Care 13: 257-297
56. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insuline resistance, hyperandrogenemia and systolic blood pressure while facilitating normal menses and pregnancy. Metabolism 43: 647-654
57. Wabitsch M (1995) Untersuchungen über die Entwicklung des Fettgewebes im Kindesalter. Adipositas 10: 12-18
58. Wabitsch M (1997) Ursachen der Adipositas im Kindes- und Jugendalter - ableitbare Konzepte für Prävention und Therapie. Der Kinderarzt
59. Wirth A (Hrsg) (1997) Adipositas: Epidemiologie, Ätiologie, Folgekrankheiten, Therapie. Springer, Berlin Heidelberg New York
60. Yen SSC (1980) The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12: 177-207
61. Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream JA (1983) A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med 309: 126-129